Profil
Petri T.
Vainio is currently the Director at White Pine Medical, Inc. He is also the Managing Director at Essex Woodlands Management, Inc., Essex Woodlands Health Ventures UK Ltd., and EUSA Pharma Holdco 1 (UK) Ltd. Additionally, he holds the position of Director at Laboratoires Majorelle SAS, EUSA Pharma (UK) Ltd., and EUSA Pharma Holdco 1 (UK) Ltd. In the past, Dr. Vainio has served as a Director at Heartport, Inc., Connetics Corp., Intuitive Surgical, Inc., GenVec, Inc., Prism Pharmaceuticals, Inc., Akubio Ltd., EUSA Pharma, Inc., CardioRhythm, Innoviva, Inc., Chroma Therapeutics Ltd., IPVALUE Management, Inc., and Healthcare Brands International Ltd. He was also a Non-Executive Director at Molecular Partners AG from 2009 to 2020.
Furthermore, he has worked as a General Partner at Sierra Ventures Management LLC and as a Professor at the University of Zurich.
Dr. Vainio obtained an MBA from Stanford University and a doctorate from the University of Helsinki.
Aktive Positionen von Petri T. Vainio
| Unternehmen | Position | Beginn |
|---|---|---|
White Pine Medical, Inc.
White Pine Medical, Inc. Medical SpecialtiesHealth Technology Manufactures and markets medical devices | Direktor/Vorstandsmitglied | 07.04.2011 |
Essex Woodlands Health Ventures UK Ltd.
Essex Woodlands Health Ventures UK Ltd. Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 01.01.2004 |
EUSA Pharma (UK) Ltd.
EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services Supplies medicines and medical devices | Direktor/Vorstandsmitglied | - |
EUSA Pharma Holdco 1 (UK) Ltd.
EUSA Pharma Holdco 1 (UK) Ltd. Medical DistributorsDistribution Services Operates as a holding company whose subsidiaries wholesales pharmaceuticatical products | Direktor/Vorstandsmitglied | 28.01.2015 |
Essex Woodlands Management, Inc.
Essex Woodlands Management, Inc. Investment ManagersFinance EW Healthcare Partners invests in public and private companies located in the North America, Latin America, Asia, and Europe with revenues ranges from USD 20 - 200 million. The firm focuses on sectors such as pharmaceutical, medical device, healthcare services, and healthcare IT. The firm participates in growth capital requirements with an investment size range from USD 20 - 100 million. It takes minority or majority interest and requires a board position. | Private Equity Investor | 01.01.2004 |
Laboratoires Majorelle SAS
Laboratoires Majorelle SAS Medical DistributorsDistribution Services Wholesales pharmaceutical products | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Petri T. Vainio
| Unternehmen | Position | Ende |
|---|---|---|
| MOLECULAR PARTNERS AG | Direktor/Vorstandsmitglied | 29.04.2020 |
Heartport, Inc.
Heartport, Inc. Medical SpecialtiesHealth Technology Develops systems and procedures for heart surgery | Direktor/Vorstandsmitglied | 28.04.2011 |
Akubio Ltd.
Akubio Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops acoustic biosensor instruments | Direktor/Vorstandsmitglied | 31.05.2010 |
| ░░░░░░░░░░ ░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Petri T. Vainio
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 24 |
|---|---|
Heartport, Inc.
Heartport, Inc. Medical SpecialtiesHealth Technology Develops systems and procedures for heart surgery | Health Technology |
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Health Technology |
Intuitive Surgical, Inc.
Intuitive Surgical, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and markets robotic surgical systems | Health Technology |
GenVec, Inc.
GenVec, Inc. Pharmaceuticals: MajorHealth Technology Develops bio-pharmaceutical products | Health Technology |
Prism Pharmaceuticals, Inc.
Prism Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cardiovascular injectibles and pharmaceutical products | Health Technology |
Akubio Ltd.
Akubio Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops acoustic biosensor instruments | Electronic Technology |
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and researches pharmaceutical products | Health Technology |
White Pine Medical, Inc.
White Pine Medical, Inc. Medical SpecialtiesHealth Technology Manufactures and markets medical devices | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sierra Ventures Management LLC
Sierra Ventures Management LLC Investment ManagersFinance Sierra Ventures invests in companies located across the globe. The firm focuses on companies operating in the fields of SaaS, AI / data, security / infrastructure, digital health, deep tech / robotics and consumer / commerce sectors. It provides financing for seed and early stage capital requirements with an investment size of USD 5 - 10 million. | Finance |
CardioRhythm
CardioRhythm Medical SpecialtiesHealth Technology Manufactures electrophysiological catheters | Health Technology |
Innoviva, Inc.
Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Chroma Therapeutics Ltd.
Chroma Therapeutics Ltd. BiotechnologyHealth Technology Engages in the discovery and development of therapies for the treatment of cancer and inflammation | Health Technology |
Essex Woodlands Management, Inc.
Essex Woodlands Management, Inc. Investment ManagersFinance EW Healthcare Partners invests in public and private companies located in the North America, Latin America, Asia, and Europe with revenues ranges from USD 20 - 200 million. The firm focuses on sectors such as pharmaceutical, medical device, healthcare services, and healthcare IT. The firm participates in growth capital requirements with an investment size range from USD 20 - 100 million. It takes minority or majority interest and requires a board position. | Finance |
IPVALUE Management, Inc.
IPVALUE Management, Inc. Miscellaneous Commercial ServicesCommercial Services Provides strategic intellectual property consultation services | Commercial Services |
University of Zurich
University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Helsinki
University of Helsinki Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Healthcare Brands International Ltd.
Healthcare Brands International Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Essex Woodlands Health Ventures UK Ltd.
Essex Woodlands Health Ventures UK Ltd. Investment ManagersFinance Functions as an alternative investment manager | Finance |
Molecular Partners AG
Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
Jazz Pharmaceuticals UK Ltd.
Jazz Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets late-stage oncology, oncology supportive care and critical care products | Health Technology |
Laboratoires Majorelle SAS
Laboratoires Majorelle SAS Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
EUSA Pharma (UK) Ltd.
EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services Supplies medicines and medical devices | Distribution Services |
EUSA Pharma Holdco 1 (UK) Ltd.
EUSA Pharma Holdco 1 (UK) Ltd. Medical DistributorsDistribution Services Operates as a holding company whose subsidiaries wholesales pharmaceuticatical products | Distribution Services |
















